Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02008903 · ClinicalTrials.gov registry record

Esophageal String Test in Eosinophilic Esophagitis

A clinical trial of Eosinophilic Esophagitis, sponsored by University of Colorado, Denver.

Active
Registry status
440
Enrollment target
6
Study locations

NCT02008903: Active study of Eosinophilic Esophagitis, sponsored by University of Colorado, Denver.

NCT02008903 is a study of Eosinophilic Esophagitis that is active but no longer recruiting, run by University of Colorado, Denver. The registered enrollment target is 440 participants, below the 854-participant average among 44 other Eosinophilic Esophagitis trials with a reported enrollment target (48% lower). The trial reports 6 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02008903, a study of Eosinophilic Esophagitis, is active but no longer recruiting, sponsored by University of Colorado, Denver.

ACTIVE NOT RECRUITING
Registry status
440 participants
Enrollment target
6
Study locations

Study Summary

The overall goal of this study is to develop a novel minimally invasive device, the Esophageal String Test (EST) to monitor esophageal inflammation during treatment of the rare disease Eosinophilic Esophagitis (EoE) in a safe and efficacious manner. This study is broken down into 2 specific aims: Specific Aim 1: Identify the EoE Biomarker Panel (EBP) that will improve the sensitivity and specificity of the EST for documenting esophageal inflammation in a 1-hour time point. Specific Aim 2: Validate the ability of the EST EBP to monitor therapeutic efficacy in a 1-hour sampling time. Funding Source - FDA OOPD

Conditions Studied

Study Locations (6)

Illinois

  • Northwestern University - Chicago
  • Lurie Children's Hospital - Chicago
  • OSF St Francis Medical Center - Peoria

Colorado

  • Children's Hospital Colorado - Aurora
  • University of Colorado Hospital - Aurora

Indiana

  • Indiana University - Indianapolis

Trial Details

FieldValue
Enrollment Target 440 participants
Start Date 2009-01
Est. Completion 2025-01
University of Colorado, Denver

1,283 total trials

What the registry record for NCT02008903 still lists

NCT02008903 is an observational study that tracks outcomes without assigning an intervention. The registered 440 participants enrollment target is mid-sized for trials with a published cap, below the 854-participant average among 44 other Eosinophilic Esophagitis trials with a reported enrollment target (48% lower).

The record links to 1 condition, with Eosinophilic Esophagitis appearing as the primary indexed condition, and to 0 interventions.

NCT02008903 lists 6 locations in 3 states (Illinois, Colorado, Indiana).

Frequently Asked Questions

What is clinical trial NCT02008903 about?

NCT02008903 is a clinical study titled "Esophageal String Test in Eosinophilic Esophagitis". The overall goal of this study is to develop a novel minimally invasive device, the Esophageal String Test (EST) to monitor esophageal inflammation during treatment of the rare disease Eosinophilic Esophagitis (EoE) in a safe and efficacious manner. This study is broken down into 2 specific aims: ...

What is the current status of trial NCT02008903?

This trial is currently active not recruiting. The enrollment target is 440 participants. The study started on 2009-01. Estimated completion is 2025-01.

What conditions does trial NCT02008903 study?

This clinical trial studies the following conditions: Eosinophilic Esophagitis.

Who is sponsoring clinical trial NCT02008903?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02008903 being conducted?

This trial has 6 study locations across Colorado, Illinois, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Eosinophilic Esophagitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02008903's enrollment target sits among peer trials

440 8th of 44 higher than 37 of 44 other Eosinophilic Esophagitis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Eosinophilic Esophagitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05114538 · 440 participants · NA

    Improving the Part C Early Intervention Service Delivery System for Children with ASD

  • NCT05117619 · 440 participants · NA

    The HOME Program for Individuals With Traumatic Brain Injury and Family Members

  • NCT05602194 · 440 participants · Phase 3

    Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma

  • NCT05624879 · 440 participants · NA

    Accelerated Resolution Therapy for Early Maladaptive Grief

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02008903, the US trial registry maintained by the National Library of Medicine. NCT02008903 (mid enrollment · multi site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.